Allicin, a SUR2 opener: Possible mechanism for the treatment of diabetic hypertension in rats

21Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

Abstract

The garlic (Allium sativum L., Amaryllidaceae) has been popularly used in the treatment of diabetes and cardiac complications. In the present work, we have studied the possible mechanisms, sulfonylurea receptor (SUR) selectivity of allicin in diabetic hypertensive rats. Diabetic hypertension was induced by intraperitoneal injection of streptozotocin (50 mg/kg) followed by daily administration of dexamethasone (10 μg/kg, s.c.). Different parameters, blood pressure and blood glucose levels were studied in the rats weekly up to eight weeks. Allicin (8 mg/ kg, p.o.) shows potent antidiabetic (*p<0.001) as well as antihypertensive effect (**p<0.001, *p<0.01). It may act as a vasodilator by hyperpolarizing the membrane of normal vascular smooth muscle cells. The hyperpolarization in vascular smooth muscle occurs due to K+ channel opener activity. Antihypertensive effect of allicin is inhibited by glibenclamide, nonselective SUR blocker while combination of allicin with nateglinide, selective SUR1 blocker exerted synergistic antihypertensive effect. The results indicates that allicin is effective in the treatment of diabetic hypertension; through a mechanism that might involve selective opening of SUR2.

Cite

CITATION STYLE

APA

Dubey, H., Singh, A., Patole, A. M., Tenpe, C. R., & Ghule, B. V. (2012). Allicin, a SUR2 opener: Possible mechanism for the treatment of diabetic hypertension in rats. Revista Brasileira de Farmacognosia, 22(5), 1053–1059. https://doi.org/10.1590/S0102-695X2012005000046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free